HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.
Hanna A Alonim, Speaker at Pediatrics Conferences
The Mifne Center and Bar Ilan University, Israel

Abstract:

The worldwide prevalence of autism points out of 2% of the population. Very early intervention may minimize the severity of the phenotypic presentation of autism during infancy when neural connections are being rapidly developed. However, intervention is contingent upon a diagnosis of autism – which in most developed countries occurs above the age of 24 months – resulting in missing a critical therapeutic opportunity for early intervention. Our study aimed to detect the prodromal variables at a very early stages during the first year of life, that may characterize significant risk for the later development of autism. The study examined 110 infants from various countries diagnosed with autism at age 2-3 years. Analysis was conducted of home videos recorded during the infants' first year of life. Data was collated and analysed in terms of individual variables and combinations of variables. Eight prodromal variables were exhibited among 89% of the infants participating in this study. The results of this study indicate that detecting the prodrome of autism depends primarily on the ability to identify various combinations of indicative symptoms. The variables elicited by this study provide the basis for an early assessment scale for prodromal variables associated with autism, which is applied clinically for infants between 5-15 months. This presentation is aimed to raise awareness of early detection, and will be accompanied by videos. Effective application of the screening scale ESPASSI© is of utility in bridging the divide between early assessment and intervention for infants at high risk for autism during the very early neurodevelopmental stages. Clinical therapeutic sample will be presented in this lecture.

Biography:

Dr. Hanna A. Alonim, is an expert and researcher in the autism spectrum in infancy. Founder and Head of the Mifne Center Israel, for Treatment, Training, and Research, since 1987. Head of the Therapists' Training School for Autism in infancy at the Bar Ilan University.  Alonim developed the ESPASSI © screening scale for the detection of autism prodrome in first year of life and established the pioneer infant’s detection Unit at the Ichilov Hospital in TLV. Dr. Alonim is a member of the Norland Journal Editorial Bord, Consistent Reviewer of JADD, and a committee member of the ICF Core Set for ASD, WHO, Stockholm 2016.

Twitter XTwitter
Watsapp